An Economic Evaluation of Ranibizumab versus Aflibercept for the treatment of Neovascular (WET) AMD in the United Kingdom

W.A. Malcolm, L. Claxton, Robert Hodgson, Matthew Taylor

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)A183
JournalValue in Health
Issue number3
Publication statusPublished - 2015
Externally publishedYes

Bibliographical note

doi: 10.1016/j.jval.2015.03.1057

Cite this